The Scholarly Kitchen's Tim Vines notes that "the opinions of highly respected senior scientists tend to get a lot of attention, and a number have lamented the state of peer review." Because of this, he asks: "What if the reviewer experience for high-profile researchers is the exception and not the rule?"

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.